Nebulev-0.63 Respules

Levosalbutamol 0.63 mg per 2.5 ml Respules — Paediatric

Nebulev-0.63 Respules — Levosalbutamol 0.63 mg per 2.5 ml from Trumac Healthcare PCD Pharma Franchise India

Composition Levosalbutamol 0.63 mg per 2.5 ml
Dosage Form Respules / Nebuliser Solution
Pack Type Unit-Dose Vials
Pack Size Strip of Respules
MRP ₹ 400
Therapy Paediatrics / Pulmonology — Selective Beta-2 Agonist (Paediatric)
Storage Store below 30 °C in a dry place, protected from light and moisture.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Nebulev-0.63 Respules

Nebulev-0.63 Respules deliver Levosalbutamol 0.63 mg per 2.5 ml via nebulisation — the paediatric strength for bronchospasm in children. Levosalbutamol is the active R-enantiomer of racemic salbutamol with less tachycardia and tremor at equivalent bronchodilator efficacy.

Manufactured by Trumac Healthcare under WHO-GMP. Available for monopoly-based PCD pharma franchise and third-party manufacturing.

Indications

  • Paediatric acute bronchospasm
  • Paediatric asthma exacerbation
  • Bronchiolitis (selected)
  • Maintenance therapy in moderate paediatric asthma

Mechanism of Action

Levosalbutamol selectively activates beta-2 adrenergic receptors on bronchial smooth muscle → cAMP elevation → bronchodilation. R-enantiomer provides bronchodilation while minimising S-enantiomer's pro-inflammatory and cardiac effects.

Dosage & Administration

Children 6–11 years: 1 respule (0.63 mg) nebulised every 6–8 hours.

Side Effects

Tachycardia, tremor (less than racemic salbutamol), hypokalaemia, nervousness.

Contraindications & Precautions

Hypersensitivity, severe cardiovascular disease, hyperthyroidism.

Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise & Third-Party Manufacturing
Nebulev-0.63 Respules is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Nebulev-0.63 Respules used for?

Nebulev-0.63 Respules contains Levosalbutamol 0.63 mg per 2.5 ml. Used as per the indications described above.

How should Nebulev-0.63 Respules be taken?

As directed by your physician. Complete the prescribed course.

Is Nebulev-0.63 Respules available for PCD pharma franchise?

Yes, Trumac Healthcare offers Nebulev-0.63 Respules on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Nebulev-0.63 Respules be stored?

Store below 30 °C in a dry place, protected from light and moisture.

Is Nebulev-0.63 Respules WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.